Results 91 to 100 of about 4,990 (167)

Overcoming Limits of Immunoconjugates [PDF]

Nature Biotechnology, 1991
openaire   +1 more source

Triple Negative Breast Cancer With Choroidal Metastasis Responsive to Sacituzumab Govitecan and Radiation Therapy. [PDF]

Cancer Rep (Hoboken)
Nafissi N, Mahadevan A, Chiao E, Rijal N, Parajuli R.   +4 more
europepmc   +1 more source

PD-1/PD-L1 Cancer Immunotherapeutics Reshape Tumor Microenvironment - Clinical Evidence and Molecular Mechanisms for AI-based Precision Medicine. [PDF]

Clin Rev Allergy Immunol
Lin YY, Ding JL, Shen HT, Lin YM, Adhidjaja EC, Chang SC.   +5 more
europepmc   +1 more source

Conjugation of anti-HIV gp41 monoclonal antibody to a drug capable of targeting resting lymphocytes produces an effective cytotoxic anti-HIV immunoconjugate. [PDF]

J Virol
Pincus SH, Cole FM, Ober K, Tokmina-Lukaszewska M, Marcotte T, Kovacs EW, Zhu T, Khasanov A, Copié V, Peters T.   +9 more
europepmc   +1 more source

Double metastatic cancer with lung and urothelial carcinoma responding to enfortumab vedotin: a case report and review of the literature. [PDF]

J Med Case Rep
Ravoire M, Vazquez L.
europepmc   +1 more source

Response to trastuzumab-deruxtecan in metastatic triple-negative breast cancer with both HER2 mutation and low expression. [PDF]

Einstein (Sao Paulo)
Amarger CD, Rabello MIS, Skaf SC, Moura F, Cassoli JPB, Taranto P, Serrano Usón Junior PL, Kaliks R, Beal JR.   +8 more
europepmc   +1 more source

Evaluating Radiotheranostic Targets for Endometrial Cancer. [PDF]

J Nucl Med
Sebastiano J, McGlone SA, Samuels ZV, Grimaldi C, Stoddard A, Galka S, Colaco E, Zeglis BM.   +7 more
europepmc   +1 more source

Interstitial pneumonitis related to sacituzumab govitecan in a patient with metastatic triple-negative breast cancer: a case report. [PDF]

J Med Case Rep
Lin MC, Lin CW.
europepmc   +1 more source

Trojan horses at leptomeningeal cellular gates: Antibody-drug conjugates deliver cytotoxic payloads. [PDF]

Med
Nikanjam M, Kurzrock R.
europepmc   +1 more source

Xoma Immunoconjugate Gets Early OK [PDF]

Nature Biotechnology, 1991
openaire   +1 more source